Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details 2)

v3.20.2
STOCKHOLDERS' EQUITY (Details 2)
9 Months Ended
Sep. 30, 2020
$ / shares
shares
Equity [Abstract]  
Unvested Restricted Stock at December 31, 2019 | shares 2,310
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 25.84
Forfeited | shares (33)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares $ 24.44
Vested | shares (923)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 22.89
Granted | shares 572
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 36.73
Unvested Restricted Stock at September 30, 2020 | shares 1,926
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 30.51